Kiran Mazumdar Shaw, founder of Biocon, has stepped down as the Director of the Company, with effect from the conclusion of the 25th Annual General Meeting that was held on August 1, 2024. This is because her second and last tenure as an Independent Director will be concluding on September 03, 2024.
Consequently, she shall also cease to be Chairperson or Member of the Nomination & Remuneration Committee, and a Member of the Corporate Social Responsibility/ Environment, Social & Governance Committee of the Board of the Company.
Shaw is the Chairperson and Managing Director of Biocon, Asia’s bio-pharmaceuticals enterprise. Named among TIime magazine’s 100 most influential people in the world, she is recognised as a global thought leader for Biotechnology.
Under her stewardship, Biocon has evolved since its inception in 1978 from an industrial enzymes company to a fully integrated, innovation-led, emerging global biopharmaceutical enterprise committed to reducing therapy costs of chronic conditions like diabetes, cancer and autoimmune diseases.
She has been recognised with the Padma Shri in 1989 and the Padma Bhushan in 2005.